SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001213900-18-015564
Filing Date
2018-11-14
Accepted
2018-11-13 19:00:30
Documents
10

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO. 1 TO THIS REGISTRATION STATEMENT posam2018a1_tizianalife.htm POS AM 3116524
2 CONSENT OF MAZARS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM, REGARDING posam2018a1ex23-1_tiziana.htm EX-23.1 2441
3 GRAPHIC image_001.jpg GRAPHIC 5487
4 GRAPHIC img_1n.jpg GRAPHIC 106643
5 GRAPHIC img_7n.jpg GRAPHIC 105446
6 GRAPHIC image_004.jpg GRAPHIC 17305
7 GRAPHIC image_005.jpg GRAPHIC 14606
8 GRAPHIC img_8n.jpg GRAPHIC 32185
9 GRAPHIC img_3n.jpg GRAPHIC 226044
10 GRAPHIC image_007.jpg GRAPHIC 15154
  Complete submission text file 0001213900-18-015564.txt   3841110
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences plc (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-226368 | Film No.: 181179887
SIC: 2834 Pharmaceutical Preparations